Flashcards · Module 5
❤️ Heart Disease in Older Adults
4 of 4 cards published · read by the site’s author on 14 November 2026
What is HFpEF, and why is it the "heart failure of old age"?
Needs clinical review
The Concept:
The heart squeezes fine (EF ≥50%) but is too stiff to relax and fill properly.
Why It Happens With Aging:
Cardiac muscle fibrosis (collagen replaces muscle)
Slow calcium reuptake (SERCA2a pump slows down)
Stiff aorta (heart has to push harder)
How to Diagnose in an 80-Year-Old:
Symptoms: Breathlessness, leg swelling, fatigue
Echo: LVEF ≥50% + average E/e′ ≥15 + left atrial enlargement
Blood test: NT-proBNP >1800 pg/mL (age >75 rule-in cut-off for acute heart failure — higher than in younger patients)
Treatment:
SGLT-2 inhibitors (Empagliflozin, Dapagliflozin) — the game-changer for HFpEF!
Loop diuretics (Furosemide) — lowest dose to relieve congestion
Control blood pressure and atrial fibrillation
Sources checked (8) · 14 November 2026
- Comparing the Prognostic Performance Using Various Diagnostic Scoring Systems in Heart Failure With Preserved Ejection Fraction: Insights From the Nationwide Prospective Registry (2026)
- Exploration of the Pathogenesis and Treatment of Heart Failure (2026)
- Clinical Symptom Burden and Its Association With Echocardiographic Parameters and Comorbidities in Heart Failure With Preserved Ejection Fraction: A Retrospective Study (2026)
- Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations. (2020)
- The Clinical Value of NT-proBNP, sST2, and Galectin-3 in the Management of Heart Failure: From Diagnosis to Dynamic Monitoring: A Narrative Review (2026)
- Implementation of guideline-directed medical therapy among patients with acute heart failure admitted to cardiac rehabilitation: the PROMETEO registry (2026)
- Assessment of Exercise Intolerance and Evaluation for HFpEF: A Literature Review of Pathophysiology, Diagnosis, and Management (2026)
- Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction (2022)
Note: Age-adjusted NT-proBNP thresholds of 450 pg/mL (<50 years), 900 pg/mL (50–75 years), and 1800 pg/mL (>75 years) are validated rule-in cutoffs for acute heart failure in the ICON RELOADED study. (The Clinical Value of NT-proBNP, sST2, and Galectin-3 in the Management of Heart Failure: From Diagnosis to Dynamic Monitoring: A Narrative Review (2026))
Blood Pressure Targets: What did HYVET and SPRINT prove?
Needs clinical review
The Two Landmark Trials:
| Trial | Patients | Target | Key Results |
|---|---|---|---|
| HYVET (2008) | Age ≥80 | SBP <150 mmHg | ↓ Death 21%, ↓ Stroke 30%, ↓ Heart failure 64% |
| SPRINT-Senior (2016) | Age ≥75 | SBP <120 mmHg (intensive) | ↓ CV events (HR 0.66), ↓ Death (HR 0.67), NO increase in falls (HR 0.91) |
Your Clinical Cheat Sheet:
| Patient Type | SBP Target |
|---|---|
| Older adults (if well tolerated) | 120–129 mmHg |
| Frail / age ≥85 / orthostatic hypotension | <140 mmHg (ALARA) |
| Prudent lower limit | Ensure DBP does not fall <60 mmHg (coronary perfusion depends on diastole!) |
The Mandatory Safety Check:
ALWAYS check standing blood pressure at 1 and 3 minutes: in older adults with low SBP (<120 mmHg in age ≥80) or severe OH, consider treatment reduction.
Sources checked (6) · 14 November 2026
- Treatment of hypertension in patients 80 years of age or older (2008)
- Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial (2016)
- The "Lower Is Better" Debate in Hypertension Management: A Narrative Review of Divergent Recommendations in the 2024 ESC and 2025 ACC/AHA Guidelines. (2026)
- Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control (2016)
- Hypertension, Atrial Fibrillation, and Orthostatic Hypotension in Older Adults: Blood Pressure Assessment and Treatment Decisions-A Narrative Review (2026)
- Applying the Systolic Blood Pressure Intervention Trial Results to Older Adults (2017)
Note: In HYVET, the 30% reduction in fatal or nonfatal stroke had a 95% CI of -1 to 51 and did not reach statistical significance (P=0.06). (Treatment of hypertension in patients 80 years of age or older (2008))
Note: Under ACC/AHA guidelines, the systolic blood pressure target is <130 mmHg (Class 1) for adults with hypertension and increased cardiovascular risk. (The "Lower Is Better" Debate in Hypertension Management: A Narrative Review of Divergent Recommendations in the 2024 ESC and 2025 ACC/AHA Guidelines. (2026))
Should you withhold blood thinners in an older patient who falls?
Needs clinical review
The Short Answer: Almost never.
The Math (Man-Son-Hing Model):
A patient on anticoagulation for atrial fibrillation would need to fall ~295 times per year for the risk of traumatic subdural hematoma to outweigh the stroke-prevention benefit.
DOACs vs. Warfarin in Older Adults:
| Feature | DOACs Win ✅ |
|---|---|
| Intracranial hemorrhage | ~50% lower than Warfarin |
| Stroke prevention | Equal or better |
| Drug/food interactions | Far fewer |
| No routine INR monitoring | Benefit over warfarin holds in frailty |
What about Aspirin as a "safer" alternative?
❌ Aspirin is NOT a safer substitute. In AVERROES, apixaban reduced stroke by >50% compared with aspirin (1.6% vs 3.7%/yr), with similar rates of major bleeding (1.4% vs 1.2%/yr).
Sources checked (4) · 14 November 2026
- Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis (2020)
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (2014)
- Oral anticoagulation therapy in nonagenarian patients with atrial fibrillation: usage patterns, predictors, and in-hospital outcomes from a single-center retrospective study (2026)
- Apixaban in patients with atrial fibrillation (2011)
Orthostatic Hypotension (OH) and Postprandial Hypotension (PPH)
Needs clinical review
Definitions:
| Condition | Criteria |
|---|---|
| Orthostatic Hypotension | SBP drop ≥20 mmHg or DBP drop ≥10 mmHg within 3 min of standing |
| Postprandial Hypotension | SBP drop ≥20 mmHg within 2 hours of eating |
Why It Happens in Old Age:
Baroreceptors in the carotid sinus/aortic arch become stiff and insensitive
Autonomic reflexes slow down
Medications (alpha-blockers, nitrates, diuretics) worsen it
Management Toolkit:
| Strategy | Details |
|---|---|
| 💊 Stop the culprits | Alpha-1 blockers (Tamsulosin), nitrates, TCAs, high-dose diuretics |
| 💧 Water bolus | Rapid ingestion of 500 mL of water before standing |
| 🧦 Compression | Waist-high stockings or abdominal binder |
| 🛏️ Head-up bed | Elevate head of bed 10–30° at night |
| 🍽️ Small meals | Small, frequent, low-carb meals (for PPH) |
| 💊 Drugs (refractory) | Midodrine (alpha-1 agonist) — take last dose at least 4 hours before bedtime to avoid supine hypertension |
Sources checked (5) · 14 November 2026
- The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension (2017)
- Visual and Semiquantitative Assessment of (123)I-Ioflupane SPECT in Probable Dementia with Lewy Bodies and Its Association with Autonomic Dysfunction: A Retrospective Study (2026)
- Hypertension and orthostatic hypotension in the elderly: a challenging balance (2025)
- Autonomic neuropathy in diabetes (2025)
- Multiple system atrophy (2023)